Clinical Trial Update: 90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients [NA]

View source ↗

Summary

The clinical trial investigating 90Second IBD for improving self-efficacy and quality of life in Crohn's disease and ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Jennifer Jones | Conditions: IBD, Crohn Disease | NA | Status: WITHDRAWN